Can the ESC/EAS LDL-cholesterol target in patients with diabetes and high cardiovascular risk be achieved in clinical practice? Results from an ambulatory multidisciplinary diabetes center cohort

Diabetes Metab. 2019 Dec;45(6):592-595. doi: 10.1016/j.diabet.2018.01.010. Epub 2018 Jan 30.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Cardiology / organization & administration
  • Cardiology / standards
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control*
  • Cholesterol, LDL / blood*
  • Cohort Studies
  • Diabetes Mellitus / blood
  • Diabetes Mellitus / therapy*
  • Diabetic Angiopathies / etiology
  • Diabetic Angiopathies / prevention & control*
  • Dyslipidemias / blood
  • Dyslipidemias / complications
  • Dyslipidemias / drug therapy
  • Europe
  • Female
  • France
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Male
  • Middle Aged
  • Patient Care Planning / standards*
  • Practice Guidelines as Topic
  • Primary Health Care / standards
  • Risk Factors
  • Societies, Medical / standards
  • Young Adult

Substances

  • Cholesterol, LDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors